drugset / Trial / NCT00621959

A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis

NCT00621959

Phase 4 Completed 596 enrolled UCB Pharma
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study objective is to investigate the efficacy of levocetirizine in reducing symptoms associated with seasonal allergic rhinitis and in improving rhinitis-related Quality of Life

Timeline

Start
2008-03
Primary completion
2008-06
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Levocetirizine Unknown 5 mg Oral